Magnetic resonance imaging contrast agent targeted toward activated platelets allows in vivo detection of thrombosis and monitoring of thrombolysis

C. von zur Muhlen; D. von Elverfeldt; J.A. Moeller; R.P. Choudhury; D. Paul; C.E. Hagemeyer; M. Olschewski; A. Becker; I. Neudorfer; N. Bassler; M. Schwarz; C. Bode; K. Peter

Circulation (2008) - Comment
pubmed: 18574047 doi: 10.1161/circulationaha.107.753657 issn: 1524-4539 issn: 0009-7322

C. Von Zur Muhlen, D. Von Elverfeldt, J.A. Moeller, R.P. Choudhury, D. Paul, C.E. Hagemeyer, M. Olschewski, A. Becker, I. Neudorfer, N. Bassler, M. Schwarz, C. Bode, K. Peter

Go to article
Go to preprint

Ovid Technologies (Wolters Kluwer Health)